MRC Holland recently announced that five SALSA MLPA assays for the detection of hereditary breast and ovarian cancer (HBOC) syndrome were recently CE-marked for in vitro diagnostic (IVD) use under the new In-Vitro Diagnostic Regulation EU 2017/746 (IVDR).

Healthcare In Europe

20.02.2025

AML: sleep problems identified as early warning sign • healthcare-in-europe.com

Amyotrophic lateral sclerosis (ALS), also known as Charcot’s disease, or Lou Gehrig’s disease, is a severe neurodegenerative disease that leads to progressive paralysis of muscles involved in voluntary movement. To date, no curative treatment exists.

Healthcare In Europe

21.02.2025

Liquid biopsy to unlock breast cancer treatments • healthcare-in-europe.com

A new study on circulating tumor DNA (ctDNA) testing for advanced breast cancer has unveiled encouraging results, with high detection rates of genetic mutations and a substantial impact on treatment decisions.

Healthcare In Europe

21.02.2025

Crohn's disease: Mesenteric-based surgery shows promise • healthcare-in-europe.com

A surgical approach pioneered in Limerick could have a global impact on the treatment of Crohn’s disease.

home›Healthcare In Europe

Healthcare In Europe

Health

IVDR certification for breast and ovarian cancer assays • healthcare-in-europe.com

AML: sleep problems identified as early warning sign • healthcare-in-europe.com

Liquid biopsy to unlock breast cancer treatments • healthcare-in-europe.com

Crohn's disease: Mesenteric-based surgery shows promise • healthcare-in-europe.com

home
›
Healthcare In Europe